ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    The Impact of a Novel Dual Adenosine Triphosphate-Competitive mTOR Inhibitor (TORKinib) on Alloimmunity and Transplant Survival.

    D. Fantus,1 Y. Ono,1 S. Yokota,1 C. Komatsu,1 H. Turnquist,1,2 A. Thomson.1,2

    1Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Rapamycin (RAPA), an immunosuppressive agent, inhibits the mechanistic target of Rapamycin (mTOR), the kinase subunit of two mTOR- containing complexes (mTORC1 and mTORC2). While…
  • 2016 American Transplant Congress

    Limiting Helper Functions of CD4 T Cells Improves Efficacy of Induction Therapy without Compromising Responses to Third Party Antigens.

    K. Ayasoufi, V. Gorbacheva, F. Ran, A. Valujskikh.

    Cleveland Clinic, Cleveland.

    Antibody mediated lymphocyte depletion is commonly used in clinical transplantation. However, memory T cells undermine the efficacy of lymphoablative induction therapies in sensitized transplant recipients.…
  • 2016 American Transplant Congress

    Belatacept Immunotherapy Is Not Augmented by Blockade of Activated LFA-1 in a Nonhuman Primate Renal Transplant Model.

    K. Samy,1 M. Mulvihill,1 B. Collins,1 D. Lo,2 M. Song,1 F. Leopardi,1 A. Kirk.1,2

    1Department of Surgery, Duke University Medical Center, Durham, NC; 2Emory University, Atlanta, GA.

    Purpose: Belatacept specifically targets de novo alloimmune responses without off target side effects. However, resistant alloreactive memory T cells have complicated its use. LFA-1 therapy…
  • 2016 American Transplant Congress

    Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells.

    T. Nakamura, K. Masuda, T. Matsuyama, H. Ushigome, N. Yoshimura.

    Department of Organ Transplantation and General Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.

    Mammalian target of rapamycin (mTOR) inhibitors are the main immunosuppressive drugs for organ transplant recipients. Nevertheless, the mechanisms by which mTOR inhibitors induce immunosuppression is…
  • 2016 American Transplant Congress

    iNKT Cell Activation Under Co-Stimulatory Blockade Establishes Mixed Chimerism Through Thymic Regulatory T Cell Activation.

    T. Hirai,1 Y. Ishii,2 R. Ishii,1 S. Miyairi,1 M. Ikemiyagi,1 M. Okumi,1 K. Tanabe.1

    1Department of Urology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan; 2Laboratory for Vaccine Design, RIKEN-IMS, Yokohama, Kanagawa, Japan.

    Background: Invariant natural killer T (iNKT) cells have recently garnered considerable attention for their potential to induce regulatory T cells (Tregs). We previously reported a…
  • 2016 American Transplant Congress

    Treg-Rich Organized Lymphoid Structures (TOLS) in Spontaneously Accepted Mouse Kidney Allografts.

    C. Yang,1 E. Farkash,2 D. Ndishabandi,1 R. White,1 B. Jiang,1 I. Aljabban,1 P. Russell,1 J. Madsen,1 R. Colvin,1 A. Alessandrini.1

    1Center for Transplantation Sciences, Dept. of Surgery, Dept. of Pathology, Massachusetts General Hospital, Boston, MA; 2University of Michigan School of Medicine, Ann Arbor, MI.

    Background: In many MHC mismatched strain combinations (e.g., DBA/2 to B6) kidney allografts are spontaneously accepted without immunosuppression. This tolerance is regulatory, initially dependent Foxp3+…
  • 2016 American Transplant Congress

    In Vitro Reactivity of CD4+ T Cells Subsets from Hosts with Antigen Specific Transplant Tolerance Mediated by CD4+CD25+T Cells.

    B. Hall, C. Robinson, K. Plain, N. Verma, G. Tran, N. Carter, M. Nomura, R. Boyd, S. Hodgkinson.

    Immune Tolerance Laboratory, UNSW Australia, Sydney, NSW, Australia.

    In animals with transplant tolerance without lympho-hemopoietic chimerism peripheral T cells reactive to donor are not deleted, but their capacity to effect rejection is inhibited…
  • 2016 American Transplant Congress

    Impact of Mixed Xenogeneic Chimerism on Human B Cell Response to Pig Antigens.

    H. Li, S. Shao, P. Vishwasrao, M. Holzl, M. Sykes.

    Columbia Center for Translational Immunology, Columbia University, New York, NY.

    Xenotransplantation is a potential solution to the organ shortage in clinical transplantation. Pigs are regarded as the most suitable donors. Studies in pig-to-nonhuman primates have…
  • 2016 American Transplant Congress

    Long Term Heterotopic Cardiac Xenograft Survival from Donor Pigs with Six Gene Modifications.

    M. Mohiuddin,1 A. Singh,1 J. Chan,1 P. Corcoran,1 M. Thomas III,2 B. Lewis,2 D. Ayares,3 K. Horvath.1

    1CSRP, NHLBI/NIH, Bethesda, MD; 2DVR / RS, NIH, Bethesda, MD; 3Revivicor, Inc, Blacksburgh, VA.

    Introduction: We have recently reported pig xenograft survival of more than 2.5 years in a heterotopic cardiac xenograft model. Some of the animals exhibited local…
  • 2016 American Transplant Congress

    Long-Term Islet Xenograft Survival Requires Effective Control of Early Xenogeneic IL-17 Response and Late Xenogeneic IFN-γ Response.

    H. Kang,1 S. Wang,2 X. Zhang,3 A. Singh,5 L. Zhang,1 W. Suarez-Pinzon,5 S. Miller,4 B. Hering,5 X. Luo.1,3,4

    1Medicine, Northwestern University, Chicago, IL; 2Surgery, Tianjin Union Medical Center, Tianjin, China; 3Comprehensive Transplant Center, Northwestern University, Chicago, IL; 4Microbiology and Immunology, Northwestern University, Chicago, IL; 5Schulze Diabetes Institute, University of Minnesota, Minneapolis, MN.

    Introduction: Tolerance induction for xenogeneic islet transplant remains a challenge. We have previously shown that peri-transplant infusion of donor cells treated with 1-ethyl-3-(3'-dimethylaminopropyl)-carbodiimide (ECDI) is…
  • « Previous Page
  • 1
  • …
  • 1207
  • 1208
  • 1209
  • 1210
  • 1211
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences